February 28, 2007 (Press Release) --
Acomplia is anoressica drug of anti-obesity.
It will be sold from Sanofi-Aventis under the denomination trades them Acomplia that begins in 2006. Rimonabant could also have been effective as drug anti-addictive in the treatment of alcoholism therefore as added of the stimulant and the nicotine. Rimonabant is an antagonist of the receiver of cannabinoid the CB1. For more visit http://acomplia.blog.co.uk
It will be sold from Sanofi-Aventis under the denomination trades them Acomplia that begins in 2006. Rimonabant could also have been effective as drug anti-addictive in the treatment of alcoholism therefore as added of the stimulant and the nicotine. Rimonabant is an antagonist of the receiver of cannabinoid the CB1. For more visit http://acomplia.blog.co.uk

http://acomplia.blog.co.uk
Email
Print
SPAM





